Skip to main content
Top
Published in: Annals of Hematology 6/2004

01-06-2004 | Rapid Communication

Platelet distribution width (PDW) is increased in vaso-occlusive crisis in sickle cell disease

Authors: Manik A. Amin, Amit P. Amin, Hemant R. Kulkarni

Published in: Annals of Hematology | Issue 6/2004

Login to get access

Abstract

Considering the multigenic and multifactorial nature of the disease, we argue that a generalized bone marrow hyperplasia—and not merely erythroid hyperplasia—will occur in sickle cell disease. Consequently, we expect the hematological parameters to depict erythroid, myeloid as well as megakaryocyte hyperplasia. In the light of this expectation, we hypothesized that platelet distribution width (PDW) will increase in sickle cell disease. Here, we report the results from a cross-sectional study of 216 children admitted with complaints suggestive of vaso-occlusive crisis. We observed a strong association between PDW and sickle cell disease as compared to children who had HbAA genotype. Our findings bridge previous inconsistencies relating to the role of platelets in sickle cell disease. Implications of this finding are discussed.
Literature
1.
go back to reference Freedman ML, Karpatkin S (1975) Elevated platelet count and megathrombocyte number in sickle cell anemia. Blood 46:579–582PubMed Freedman ML, Karpatkin S (1975) Elevated platelet count and megathrombocyte number in sickle cell anemia. Blood 46:579–582PubMed
2.
go back to reference Bessman JD, Gilmer PR, Gardner FH (1985) Use of mean platelet volume improves detection of platelet disorders. Blood Cells 11:127–135PubMed Bessman JD, Gilmer PR, Gardner FH (1985) Use of mean platelet volume improves detection of platelet disorders. Blood Cells 11:127–135PubMed
3.
go back to reference Croizat H, Ponchio L, Nicolini FE, Nagel RL, Eaves CJ (2000) Primitive haematopoietic progenitors in the blood of patients with sickle cell disease appear to be endogenously mobilized. Br J Haematol 111:491–497CrossRefPubMed Croizat H, Ponchio L, Nicolini FE, Nagel RL, Eaves CJ (2000) Primitive haematopoietic progenitors in the blood of patients with sickle cell disease appear to be endogenously mobilized. Br J Haematol 111:491–497CrossRefPubMed
4.
go back to reference Blouin M-J, De Paepe ME, Trudel M (1999) Altered hematopoiesis in murine sickle cell disease. Blood 94:1451–1459 Blouin M-J, De Paepe ME, Trudel M (1999) Altered hematopoiesis in murine sickle cell disease. Blood 94:1451–1459
5.
go back to reference Wun T, Paglieroni T, Tablin F, Welborn J, Nelson K, Cheung A (1997) Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia. J Lab Clin Med 129:507–516PubMed Wun T, Paglieroni T, Tablin F, Welborn J, Nelson K, Cheung A (1997) Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia. J Lab Clin Med 129:507–516PubMed
6.
go back to reference Wun T, Paglieroni T, Field CL, Welborn J, Cheung A, Walker NJ, Tablin F (1999) Platelet-erythrocyte adhesion in sickle cell disease. J Investig Med 47:121–127 Wun T, Paglieroni T, Field CL, Welborn J, Cheung A, Walker NJ, Tablin F (1999) Platelet-erythrocyte adhesion in sickle cell disease. J Investig Med 47:121–127
7.
go back to reference Antonucci R, Walker R, Herion J, Orringer E (1990) Enhancement of sickle erythrocyte adherence to endothelium by autologous platelets. Am J Hematol 34:44–48PubMed Antonucci R, Walker R, Herion J, Orringer E (1990) Enhancement of sickle erythrocyte adherence to endothelium by autologous platelets. Am J Hematol 34:44–48PubMed
8.
go back to reference Beurling-Harbury C, Schade SG (1989) Platelet activation during pain crisis in sickle cell anemia patients. Am J Hematol 31:237–241PubMed Beurling-Harbury C, Schade SG (1989) Platelet activation during pain crisis in sickle cell anemia patients. Am J Hematol 31:237–241PubMed
9.
go back to reference Westwick J, Watson-Williams EJ, Krishnamurthi S, Marks G, Ellis V, Scully MF, White JM, Kakkar VV (1983) Platelet activation during steady state sickle cell disease. J Med 14:17–36PubMed Westwick J, Watson-Williams EJ, Krishnamurthi S, Marks G, Ellis V, Scully MF, White JM, Kakkar VV (1983) Platelet activation during steady state sickle cell disease. J Med 14:17–36PubMed
10.
go back to reference Semple MJ, Al-Hasani SF, Kioy P, Savidge GF (1984) A double-blind trial of ticlopidine in sickle cell disease. Thromb Haemost 51:303–306 Semple MJ, Al-Hasani SF, Kioy P, Savidge GF (1984) A double-blind trial of ticlopidine in sickle cell disease. Thromb Haemost 51:303–306
11.
go back to reference Greenberg J, Ohene-Frempong K, Halus J, Way C, Schwartz E (1983) Trial of low doses of aspirin as prophylaxis in sickle cell disease. J Pediatr 102:781–784PubMed Greenberg J, Ohene-Frempong K, Halus J, Way C, Schwartz E (1983) Trial of low doses of aspirin as prophylaxis in sickle cell disease. J Pediatr 102:781–784PubMed
12.
go back to reference Osselaer J-C, Jamart J, Scheiff J-M (1997) Platelet distribution width for differential diagnosis of thrombocytosis. Clin Chem 43:1072–1076PubMed Osselaer J-C, Jamart J, Scheiff J-M (1997) Platelet distribution width for differential diagnosis of thrombocytosis. Clin Chem 43:1072–1076PubMed
13.
go back to reference DeMaeyer EM, Dallman P, Gurney JM, Hallberg L, Sood SK, Srikantia SG (1989) Preventing and controlling iron deficiency anemia through primary health care. World Health Organization, Geneva, pp 8–9 DeMaeyer EM, Dallman P, Gurney JM, Hallberg L, Sood SK, Srikantia SG (1989) Preventing and controlling iron deficiency anemia through primary health care. World Health Organization, Geneva, pp 8–9
14.
go back to reference Sherriff A, Emond A, Hawkins N, Golding J, ALSPAC Children in Focus Study Team (1999) Hemoglobin and ferritin concentration in children aged 12 and 18 months. Arch Dis Child 80:153–157PubMed Sherriff A, Emond A, Hawkins N, Golding J, ALSPAC Children in Focus Study Team (1999) Hemoglobin and ferritin concentration in children aged 12 and 18 months. Arch Dis Child 80:153–157PubMed
15.
go back to reference Kapur D, Agarwal KN, Sharma S, Kela K, Kaur I (2002) Iron status of children aged 9–36 months in an urban slum Integrated Child Development Services Project in Delhi. Indian Pediatr 39:136–144PubMed Kapur D, Agarwal KN, Sharma S, Kela K, Kaur I (2002) Iron status of children aged 9–36 months in an urban slum Integrated Child Development Services Project in Delhi. Indian Pediatr 39:136–144PubMed
16.
go back to reference Singhal A, Davies P, Sahota A, Thomas PW, Serjeant GR (1993) Resting metabolic rate in homozygous sickle cell disease. Am J Clin Nutr 57:32–34PubMed Singhal A, Davies P, Sahota A, Thomas PW, Serjeant GR (1993) Resting metabolic rate in homozygous sickle cell disease. Am J Clin Nutr 57:32–34PubMed
17.
go back to reference Cazzola M, Pootrakul P, Bergamaschi G, Huebers HA, Eng M, Finch CA (1987) Adequacy of iron supply for erythropoiesis: in vivo observations in humans. J Lab Clin Med 110:734–739PubMed Cazzola M, Pootrakul P, Bergamaschi G, Huebers HA, Eng M, Finch CA (1987) Adequacy of iron supply for erythropoiesis: in vivo observations in humans. J Lab Clin Med 110:734–739PubMed
18.
go back to reference Tabbara IA (1992) Hemolytic anemias. Diagnosis and management. Med Clin North Am 76:649–668 Tabbara IA (1992) Hemolytic anemias. Diagnosis and management. Med Clin North Am 76:649–668
19.
go back to reference Rao KR, Patel AR, Honig GR, Vida LN, McGinnis PR (1983) Iron deficiency and sickle cell anemia. Arch Intern Med 143:1030–1032CrossRefPubMed Rao KR, Patel AR, Honig GR, Vida LN, McGinnis PR (1983) Iron deficiency and sickle cell anemia. Arch Intern Med 143:1030–1032CrossRefPubMed
20.
go back to reference Grossmann A, Maggio-Price L, Shiota FM, Liggitt DV (1993) Pathologic features associated with decreased longevity of mutant sphha/sphha mice with chronic hemolytic anemia: similarities to sequelae of sickle cell anemia in humans. Lab Anim Sci 43:217–221PubMed Grossmann A, Maggio-Price L, Shiota FM, Liggitt DV (1993) Pathologic features associated with decreased longevity of mutant sphha/sphha mice with chronic hemolytic anemia: similarities to sequelae of sickle cell anemia in humans. Lab Anim Sci 43:217–221PubMed
21.
go back to reference Farrugia A (1995) Platelet size analysis in the quality assurance of platelet concentrates for transfusion. Clin Lab Haematol 17:51–55PubMed Farrugia A (1995) Platelet size analysis in the quality assurance of platelet concentrates for transfusion. Clin Lab Haematol 17:51–55PubMed
22.
go back to reference Okpala I, Daniel Y, Haynes R, Odoemene D, Goldman J (2002) Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells. Eur J Haematol 69:135–144CrossRefPubMed Okpala I, Daniel Y, Haynes R, Odoemene D, Goldman J (2002) Relationship between the clinical manifestations of sickle cell disease and the expression of adhesion molecules on white blood cells. Eur J Haematol 69:135–144CrossRefPubMed
23.
go back to reference Anyaegbu CC, Okpala IE, Aken’Ova AY, Salimonu LS (1998) Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia. Eur J Haematol 60:267–268PubMed Anyaegbu CC, Okpala IE, Aken’Ova AY, Salimonu LS (1998) Peripheral blood neutrophil count and candidacidal activity correlate with the clinical severity of sickle cell anaemia. Eur J Haematol 60:267–268PubMed
24.
go back to reference Abboud MR, Laver J, Blau CA (1996) Elevation of neutrophil count after G-CSF therapy leads to vaso-occlusive crisis and acute chest syndrome in a patient with sickle cell anaemia. Blood 88:15b Abboud MR, Laver J, Blau CA (1996) Elevation of neutrophil count after G-CSF therapy leads to vaso-occlusive crisis and acute chest syndrome in a patient with sickle cell anaemia. Blood 88:15b
25.
go back to reference Olatunji PO, Davies SC (2000) The predictive value of white cell count in assessing clinical severity of sickle cell anaemia in Afro-Caribbean patients. Afr J Med Med Sci 29:27–30PubMed Olatunji PO, Davies SC (2000) The predictive value of white cell count in assessing clinical severity of sickle cell anaemia in Afro-Caribbean patients. Afr J Med Med Sci 29:27–30PubMed
26.
go back to reference Awogu AU (2000) Leucocyte counts in children with sickle cell anaemia usefulness of stable state values during infections. West Afr J Med 19:55–58PubMed Awogu AU (2000) Leucocyte counts in children with sickle cell anaemia usefulness of stable state values during infections. West Afr J Med 19:55–58PubMed
27.
go back to reference Lopez BL, Griswold SK, Navek A, Urbanski L (1996) The complete blood count and reticulocyte count—are they necessary in the evaluation of acute vasoocclusive sickle-cell crisis? Acad Emerg Med 3:751–757PubMed Lopez BL, Griswold SK, Navek A, Urbanski L (1996) The complete blood count and reticulocyte count—are they necessary in the evaluation of acute vasoocclusive sickle-cell crisis? Acad Emerg Med 3:751–757PubMed
28.
go back to reference Grant MM, Gil KM, Floyd MY, Abrams M (2000) Depression and functioning in relation to health are use in sickle cell disease. Ann Behav Med 22:149–157PubMed Grant MM, Gil KM, Floyd MY, Abrams M (2000) Depression and functioning in relation to health are use in sickle cell disease. Ann Behav Med 22:149–157PubMed
29.
go back to reference Midence K, McManus C, Fuggle P, Davies S (1996) Psychological adjustment and family functioning in a group of British children with sickle cell disease: preliminary empirical findings and a meta-analysis.Br J Clin Psychol 35:439–450PubMed Midence K, McManus C, Fuggle P, Davies S (1996) Psychological adjustment and family functioning in a group of British children with sickle cell disease: preliminary empirical findings and a meta-analysis.Br J Clin Psychol 35:439–450PubMed
30.
go back to reference Yang YM, Cepeda M, Price C, Shah A, Mankad V (1994) Depression in children and adolescents with sickle-cell disease. Arch Pediatr Adolesc Med 148:457–460PubMed Yang YM, Cepeda M, Price C, Shah A, Mankad V (1994) Depression in children and adolescents with sickle-cell disease. Arch Pediatr Adolesc Med 148:457–460PubMed
31.
go back to reference Gaston M, Rosse WF (1982) The cooperative study of sickle cell disease: review of study design and objectives Am J Pediatr Hematol Oncol 4:197–201 Gaston M, Rosse WF (1982) The cooperative study of sickle cell disease: review of study design and objectives Am J Pediatr Hematol Oncol 4:197–201
32.
go back to reference Nagel RL, Steinberg MH (2001) Role of epistatic (modifier) genes in the modulation of the phenotypic diversity of sickle cell anemia. Pediatr Pathol Mol Med 20:123–136CrossRefPubMed Nagel RL, Steinberg MH (2001) Role of epistatic (modifier) genes in the modulation of the phenotypic diversity of sickle cell anemia. Pediatr Pathol Mol Med 20:123–136CrossRefPubMed
33.
go back to reference Steinberg MH, Rodgers GP (2001) Pathophysiology of sickle cell disease: role of cellular and genetic modifiers. Semin Hematol 38:299–306CrossRefPubMed Steinberg MH, Rodgers GP (2001) Pathophysiology of sickle cell disease: role of cellular and genetic modifiers. Semin Hematol 38:299–306CrossRefPubMed
34.
go back to reference Nagel RL (2001) Pleiotropic and epistatic effects in sickle cell anemia. Curr Opin Hematol 8:105–110CrossRefPubMed Nagel RL (2001) Pleiotropic and epistatic effects in sickle cell anemia. Curr Opin Hematol 8:105–110CrossRefPubMed
Metadata
Title
Platelet distribution width (PDW) is increased in vaso-occlusive crisis in sickle cell disease
Authors
Manik A. Amin
Amit P. Amin
Hemant R. Kulkarni
Publication date
01-06-2004
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 6/2004
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-003-0833-8

Other articles of this Issue 6/2004

Annals of Hematology 6/2004 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine